Organization · Venture Capital

Green Park & Golf Ventures

Green Park & Golf Ventures is a Dallas-based venture capital firm that focuses on early-stage investments, primarily in the medical sector. The firm aims to provide above-market returns through strategic solutions and financial backing.

Venture CapitalFunder

Official website Official pitch route

Overview

What Green Park & Golf Ventures does

What Green Park & Golf Ventures is

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status: Active
Organization type: Venture Capital
Structured capabilities: Funder
Last reviewed: March 18, 2026

Official channels

Find Green Park & Golf Ventures elsewhere

Open the official website or a supported primary organization account.

WebsiteOfficial channel

Capability profile

Green Park & Golf Ventures as a funder

Official pitch route

Investment thesis

Green Park & Golf Ventures focuses on early-stage investments in medical-related start-ups that demonstrate innovative ideas and strong management teams, aiming for above-market returns.

Focus narrative

The firm invests in early-stage companies, particularly within the medical sector. Green Park & Golf Ventures emphasizes investments in companies that exhibit compassion, innovative ideas, and strong management teams, operating in large markets with high barriers to entry. Typical investments range from $500,000 to $2,000,000, aimed at providing start-up or growth capital.

Value beyond capital

Green Park & Golf Ventures adds value to its portfolio companies by leveraging its extensive operational and financial experience, providing strategic guidance, and facilitating connections within the medical industry to enhance growth and innovation.

Terms and economics

Typical check: $500,000–$2,000,000

Focus and fit

Stages: Pre-seed · Seed · Seed+ · Series A
Sectors: Healthcare Biotech & Life Sciences
Regions: United States

Availability

Currently deploying: Yes

Portfolio and track record

Recorded portfolio count: 15

Portfolio context

Notable portfolio companies include: Empirical Spine: Develops LimiFlex, a treatment alternative for spinal stenosis with instability. Esculon: Creates cardiothoracic post-operative medical equipment, including the Thoraguard surgical drainage system. Mission Bio: Focuses on single-cell biology to enhance precision medicine. MicroTransponder Inc: Offers the Vivistim® System for post-stroke upper limb impairment. Corvion: Works on a fully implantable left ventricular assist device (LVAD). RTRS Technologies: Innovates in dental implantology. Accuryn: Develops a monitoring system that enhances traditional Foley catheters. Channel Medsystems: Provides cryothermic treatment for heavy menstrual bleeding. Ataia Medical: Offers a communicator for patients undergoing respiratory therapies. Novascan: Focuses on improving cancer detection technologies. Noninvasix: Develops non-invasive precision oximetry solutions. Access Vascular: Creates venous access devices with patented biomaterials. Lantern Pharma: Utilizes AI for oncology drug discovery. Betaliq, Inc: Develops topical glaucoma treatments. Stingray Therapeutics: Works on innate immunity modulators. OncoNano Medicine: Develops products for cancer diagnosis and treatment. Barricade Therapeutics: Focuses on novel small molecules for cancer and neurology.

Connected ecosystem